IL158735A0 - Novel ligand for nicotinic acetylcholine receptors useful in therapy - Google Patents

Novel ligand for nicotinic acetylcholine receptors useful in therapy

Info

Publication number: IL158735A0
Authority: IL; Israel
Prior art keywords: therapy; nicotinic acetylcholine; acetylcholine receptors; novel ligand; receptors useful
Prior art date: 2001-06-01

Application number

IL15873502A

Other languages

English (en)

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-06-01

Filing date

2002-05-29

Publication date

2004-05-12

2002-05-29 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2004-05-12 Publication of IL158735A0 publication Critical patent/IL158735A0/xx

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes

IL15873502A 2001-06-01 2002-05-29 Novel ligand for nicotinic acetylcholine receptors useful in therapy IL158735A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US29520601P	2001-06-01	2001-06-01
PCT/SE2002/001031 WO2002096912A1 (en)	2001-06-01	2002-05-29	Novel ligand for nicotinic acetylcholine receptors useful in therapy

Publications (1)

Publication Number	Publication Date
IL158735A0 true IL158735A0 (en)	2004-05-12

Family

ID=23136711

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL15873502A IL158735A0 (en)	2001-06-01	2002-05-29	Novel ligand for nicotinic acetylcholine receptors useful in therapy

Country Status (19)

Country	Link
EP (1)	EP1397366B1 (pt)
JP (1)	JP2004532877A (pt)
KR (1)	KR20040003021A (pt)
CN (1)	CN1294136C (pt)
AT (1)	ATE353332T1 (pt)
BR (1)	BR0210075A (pt)
CA (1)	CA2455341A1 (pt)
DE (1)	DE60218032T2 (pt)
DK (1)	DK1397366T3 (pt)
ES (1)	ES2280538T3 (pt)
HK (1)	HK1063787A1 (pt)
IL (1)	IL158735A0 (pt)
MX (1)	MXPA03010996A (pt)
NO (1)	NO20035333D0 (pt)
NZ (1)	NZ529426A (pt)
PT (1)	PT1397366E (pt)
SI (1)	SI1397366T1 (pt)
WO (1)	WO2002096912A1 (pt)
ZA (1)	ZA200308779B (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10164139A1 (de)	2001-12-27	2003-07-10	Bayer Ag	2-Heteroarylcarbonsäureamide
JP4511195B2 (ja) *	2002-04-18	2010-07-28	アストラゼネカ・アクチエボラーグ	フリル化合物
JP4511196B2 (ja)	2002-04-18	2010-07-28	アストラゼネカ・アクチエボラーグ	チエニル化合物
DE60328010D1 (de) *	2002-04-18	2009-07-30	Astrazeneca Ab	Heterocyclische verbindungen
JP4855264B2 (ja)	2003-10-21	2012-01-18	アストラゼネカ・アクチエボラーグ	スピロフロピリジンアリール誘導体
TW200813067A (en) *	2006-05-17	2008-03-16	Astrazeneca Ab	Nicotinic acetylcholine receptor ligands
SA08290475B1 (ar)	2007-08-02	2013-06-22	Targacept Inc	(2s، 3r)-n-(2-((3-بيردينيل)ميثيل)-1-آزا بيسيكلو[2، 2، 2]أوكت-3-يل)بنزو فيوران-2-كربوكساميد، وصور أملاحه الجديدة وطرق استخدامه
AU2009260905B2 (en)	2008-06-20	2012-08-23	Astrazeneca Ab	Dibenzothiazepine derivatives and use thereof
TW201031664A (en)	2009-01-26	2010-09-01	Targacept Inc	Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide
PT3029039T (pt)	2010-05-17	2017-11-28	Forum Pharmaceuticals Inc	Formulações farmacêuticas que compreendem formas cristalinas de cloridrato de (r)-7-cloro-n-(quinuclidin-3-il)benzo(b)tiofeno-2-carboxamida mono-hidratado
GB201111705D0 (en)	2011-07-07	2011-08-24	Takeda Pharmaceutical	Compounds and their use
GB201111704D0 (en)	2011-07-07	2011-08-24	Takeda Pharmaceutical	Novel compounds
JO3115B1 (ar)	2011-08-22	2017-09-20	Takeda Pharmaceuticals Co	مركبات بيريدازينون واستخدامها كمثبطات daao
CA2872005A1 (en)	2012-05-08	2013-11-14	Forum Pharmaceuticals, Inc.	Methods of maintaining, treating or improving cognitive function
GB201209587D0 (en)	2012-05-30	2012-07-11	Takeda Pharmaceutical	Therapeutic compounds
EP2953940B1 (en)	2013-02-07	2018-08-22	Heptares Therapeutics Limited	Piperidin-1-yl and azepin-1-yl carboxylates as muscarinic m4 receptor agonists
CN105324372B (zh)	2013-06-21	2018-03-06	武田药品工业株式会社	作为前动力蛋白受体调节剂的1‑磺酰基哌啶衍生物
GB201314286D0 (en)	2013-08-08	2013-09-25	Takeda Pharmaceutical	Therapeutic Compounds
GB201318222D0 (en)	2013-10-15	2013-11-27	Takeda Pharmaceutical	Novel compounds
GB201320905D0 (en)	2013-11-27	2014-01-08	Takeda Pharmaceutical	Therapeutic compounds
TW201613864A (en)	2014-02-20	2016-04-16	Takeda Pharmaceutical	Novel compounds
GB201616839D0 (en)	2016-10-04	2016-11-16	Takeda Pharmaceutical Company Limited	Therapeutic compounds
GB201619514D0 (en)	2016-11-18	2017-01-04	Takeda Pharmaceuticals Co	Novel compounds
JP2021138648A (ja)	2020-03-04	2021-09-16	武田薬品工業株式会社	経口固形製剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0984970B1 (en) *	1997-05-30	2003-11-19	Neurosearch A/S	Spiro-quinuclidine derivatives, their preparation and use
AR013184A1 (es) *	1997-07-18	2000-12-13	Astrazeneca Ab	Aminas heterociclicas espiroazobiciclicas, composicion farmaceutica, uso de dichas aminas para preparar medicamentos y metodo de tratamiento o profilaxis
SE9900100D0 (sv) *	1999-01-15	1999-01-15	Astra Ab	New compounds

2002
- 2002-05-29 MX MXPA03010996A patent/MXPA03010996A/es active IP Right Grant
- 2002-05-29 CA CA002455341A patent/CA2455341A1/en not_active Abandoned
- 2002-05-29 NZ NZ529426A patent/NZ529426A/en unknown
- 2002-05-29 PT PT02731063T patent/PT1397366E/pt unknown
- 2002-05-29 JP JP2003500091A patent/JP2004532877A/ja active Pending
- 2002-05-29 AT AT02731063T patent/ATE353332T1/de not_active IP Right Cessation
- 2002-05-29 DK DK02731063T patent/DK1397366T3/da active
- 2002-05-29 EP EP02731063A patent/EP1397366B1/en not_active Expired - Lifetime
- 2002-05-29 IL IL15873502A patent/IL158735A0/xx unknown
- 2002-05-29 KR KR10-2003-7015462A patent/KR20040003021A/ko not_active Application Discontinuation
- 2002-05-29 WO PCT/SE2002/001031 patent/WO2002096912A1/en active IP Right Grant
- 2002-05-29 SI SI200230510T patent/SI1397366T1/sl unknown
- 2002-05-29 ES ES02731063T patent/ES2280538T3/es not_active Expired - Lifetime
- 2002-05-29 BR BR0210075-4A patent/BR0210075A/pt not_active IP Right Cessation
- 2002-05-29 DE DE60218032T patent/DE60218032T2/de not_active Expired - Fee Related
- 2002-05-29 CN CNB028110498A patent/CN1294136C/zh not_active Expired - Fee Related
2003
- 2003-11-11 ZA ZA200308779A patent/ZA200308779B/en unknown
- 2003-11-28 NO NO20035333A patent/NO20035333D0/no unknown
2004
- 2004-09-01 HK HK04106588A patent/HK1063787A1/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
ES2280538T3 (es)	2007-09-16
MXPA03010996A (es)	2004-02-27
CA2455341A1 (en)	2002-12-05
DE60218032D1 (de)	2007-03-22
KR20040003021A (ko)	2004-01-07
WO2002096912A1 (en)	2002-12-05
CN1294136C (zh)	2007-01-10
BR0210075A (pt)	2004-08-17
NO20035333D0 (no)	2003-11-28
ATE353332T1 (de)	2007-02-15
DE60218032T2 (de)	2007-08-16
ZA200308779B (en)	2005-02-11
JP2004532877A (ja)	2004-10-28
EP1397366B1 (en)	2007-02-07
NZ529426A (en)	2005-07-29
EP1397366A1 (en)	2004-03-17
PT1397366E (pt)	2007-04-30
HK1063787A1 (en)	2005-01-14
CN1512995A (zh)	2004-07-14
DK1397366T3 (da)	2007-05-07
SI1397366T1 (sl)	2007-06-30

Publication	Publication Date	Title
IL158735A0 (en)	2004-05-12	Novel ligand for nicotinic acetylcholine receptors useful in therapy
MXPA03006093A (es)	2005-02-14	Derivados de n(fenilsulfonil)glicina y su uso terapeutico.
CY1113054T1 (el)	2016-04-13	Παραγωγα διαμινης
MY134892A (en)	2007-12-31	Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and their use
DE60112974D1 (en)	2005-09-29	Carbolinderivate
MXPA03011039A (es)	2004-03-19	Nuevos compuestos heterociclicos, su preparacion y uso como medicamentos, particularmente como agentes anti-bacterianos.
RS51444B (sr)	2011-04-30	JEDINJENJA KOJA SADRŽE LAKTAM I NJIHOVI DERIVATI KAO INHIBITORI FAKTORA Xa
ATE417049T1 (de)	2008-12-15	Biaryldiazabicycloalkanamide als nicotinische acetylcholinagonisten
IL164511A0 (en)	2005-12-18	Heterocyclic compounds
HK1079522A1 (en)	2006-04-07	Thienyl compounds
GEP20105081B (en)	2010-09-27	Pyrrolotriazine compounds as kinase inhibitors
UA84712C2 (en)	2008-11-25	N-substituted pyrazolyl-amidyl-benzimidazolyl c-kit inhibitors
DE60216233D1 (en)	2007-01-04	Carbolinderivate
MX2007006743A (es)	2007-07-09	Ligandos del receptor de acetilcolina nicotinica.
YU39803A (sh)	2006-05-25	Jedinjenja piperazinilpirazina kao agonisti ili antagonisti serotonin 5ht-2-receptora
AU2001266575A1 (en)	2002-01-08	Chemical compounds
WO2002070469A3 (en)	2004-03-04	Selective pde3b inhibitors and use of the same in therapy
ATE370952T1 (de)	2007-09-15	Neue verbindungen
TW200508199A (en)	2005-03-01	Novel compound
GB0018951D0 (en)	2000-09-20	Novel compounds
RS20050364A (en)	2007-08-03	Imidazoquinoline derivatives as adenosine a3 receptor ligands
TR200402546T4 (tr)	2004-12-21	Taksan türevleri hazırlamak için işlem.
GB0027705D0 (en)	2000-12-27	Novel compounds
MXPA05003315A (es)	2005-10-18	Un sistema de liberacion controlada que contiene temozolomida.
MXPA02012472A (es)	2004-01-26	Compuestos quimicos.